Mirabaud & Cie’s MetLife MET Stock Holding History

Mirabaud & Cie’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-24,300	Closed	-$1.61M	–	63
2023 Q4	$1.61M	Buy	+24,300	New	+$1.52M	0.54%	38

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Mirabaud & Cie's MET Position: Q1 2024 in Review

Mirabaud & Cie sold out of MetLife (MET) in Q1 2024, closing a stake of 24,300 shares — an estimated $1.61M sold.

Mirabaud & Cie first reported a position in MET in Q4 2023 and held it in 1 quarter. The position peaked at $1.61M in Q4 2023. 1,282 funds tracked by Wall St. Rank hold MET as of Q1 2024.

Mirabaud & Cie reported no remaining MetLife position as of Q1 2024 after selling out during the quarter.
Mirabaud & Cie sold 24,300 MetLife shares in Q1 2024, an estimated $1.61M.
Mirabaud & Cie first reported a position in MetLife in Q4 2023 and held it in 1 quarter.
Mirabaud & Cie's MetLife position peaked at $1.61M in Q4 2023.
1,282 funds tracked by Wall St. Rank held MetLife as of Q1 2024.

Based on Mirabaud & Cie's 13F filing for Q1 2024, filed 15 Oct 2024.